Next Article in Journal
Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect
Next Article in Special Issue
Precision Immuno-Oncology in NSCLC through Gender Equity Lenses
Previous Article in Journal
Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, Socioeconomic Status, and Insurance Type
Previous Article in Special Issue
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer
 
 
Article

Article Versions Notes

Cancers 2023, 15(23), 5587; https://doi.org/10.3390/cancers15235587
Action Date Notes Link
article xml file uploaded 26 November 2023 06:51 CET Original file -
article xml uploaded. 26 November 2023 06:51 CET Update https://www.mdpi.com/2072-6694/15/23/5587/xml
article pdf uploaded. 26 November 2023 06:51 CET Version of Record https://www.mdpi.com/2072-6694/15/23/5587/pdf
article supplementary file uploaded. 26 November 2023 06:51 CET - https://www.mdpi.com/2072-6694/15/23/5587#supplementary
article html file updated 26 November 2023 06:52 CET Original file https://www.mdpi.com/2072-6694/15/23/5587/html
Back to TopTop